Company news
Metastat Inc (OTC:MTST) news
Metastat Inc news releases on 6ix. Latest, Jul 16, 2018: MetaStat Voluntarily Withdraws Listing on the OTCQB and Files Form 15 to Suspend its Reporting…
Press releases & updates
MetaStat Voluntarily Withdraws Listing on the OTCQB and Files Form 15 to Suspend its Reporting Obligations
July 16, 2018
MetaStat Presents Positive Data Showing Inhibition of the MENA-pathway Reduces Cancer Cell Dissemination and Paclitaxel Resistance in Aggressive Cancer
June 21, 2018
MetaStat Announces Positive Topline Data Showing Over 50% Reduction in Cancer Metastasis from Preclinical Studies Evaluating Inhibition of the MAPKAPK2 Kinase Pathway
February 28, 2018
MetaStat Announces Upcoming Investor and Pharmaceutical Industry Partnering Conference Presentations
September 25, 2017
MetaStat Welcomes Renato T. Skerlj, Ph.D., Accomplished Drug Developer to Its Scientific and Clinical Advisory Board
August 3, 2017
Study Demonstrates Paclitaxel Treatment Promotes Breast Cancer Dissemination and Metastasis in a Mena-dependent Manner
July 19, 2017
MetaStat Closes First Round of a $7 Million Private Placement
June 27, 2017
MetaStat Announces Completion of Second Milestone of its Pilot Research Project with Celgene Corporation
June 19, 2017
MetaStat Expands Therapeutic and Companion Diagnostic Intellectual Property Portfolio
May 23, 2017
MetaStat Elevates Jerome B. Zeldis, M.D., Ph.D. to Chairman of the Board and Appoints Douglas A. Hamilton, MetaStat’s President and CEO to its Board of Directors
May 8, 2017
Mena Expression is Associated with Paclitaxel-mediated Increase in Cancer Cell Dissemination
April 6, 2017
MetaStat to Present at the 19th Annual BIO CEO & Investor Conference
February 8, 2017
MetaStat, Inc. to Present at Biotech Showcase™ 2017
January 9, 2017
MetaStat Receives Additional State Clinical Laboratory Licenses
December 19, 2016
MetaStat Presents Positive Data from Two Clinical Studies of MetaSite Breast™ at 2016 San Antonio Breast Cancer Symposium
December 13, 2016
MetaStat, Inc. Closes Private Placement of Common Stock and Warrants
October 27, 2016
MetaStat, Inc. to Present at the 2016 BIO Investor Forum in San Francisco
October 19, 2016
MetaStat, Inc. to Present at SeeThruEquity Fall Microcap Investor Conference in New York City
October 17, 2016
MetaStat Announces Presentation of Two MetaSite Breast™ Studies at the 2016 San Antonio Breast Cancer Symposium
August 29, 2016
MetaStat Appoints Jerome B. Zeldis, M.D., Ph.D. to its Board of Directors
April 27, 2016
MetaStat Announces Successful Analytical Validation of its MenaCalc™ Cancer Diagnostic Platform
January 26, 2016
MetaStat Presents Positive Analytical Validation Data for MetaSite Breast™ Cancer Diagnostic Test
December 2, 2015
MetaStat Receives CLIA Certification from the Centers for Medicare and Medicaid Services
November 30, 2015
MetaStat Announces Reverse Stock Split in Preparation for a Proposed Uplisting to a National Market
October 7, 2015
MetaStat Receives Massachusetts State Clinical Laboratory License
September 28, 2015
MetaStat Announces Positive Topline Results of a MetaSite Breast™ Prognostic Study in Invasive Breast Cancer
September 23, 2015
MetaStat Announces Positive Topline Results of a MetaSite Breast(TM) Prognostic Study in Invasive Breast Cancer
September 23, 2015
Award Winning Cancer Researcher, Dr. Bruce R. Zetter, Joins MetaStat, Inc. Scientific and Clinical Advisory Board
September 10, 2015
MetaStat, Inc. Announces Positive Results of a MenaCalc(TM) Prognostic Study of Axillary Node-Negative Breast Cancer
September 2, 2015
MetaStat Announces Successful Analytical Validation of its MetaSite Breast™ Cancer Diagnostic
August 27, 2015
MetaStat, Inc. Appoints Michael J. Donovan, PhD, MD as Chief Medical Officer
August 17, 2015
MetaStat Raises Additional Capital in Private Placement
August 5, 2015
MetaStat Shareholders Approve Reverse Stock Split
June 23, 2015
MetaStat, Inc. Announces Douglas A. Hamilton Named President, Chief Executive Officer
June 18, 2015
MetaStat Demonstrates MenaCalc Lung™ Is Prognostic for Outcome in Non-Small Cell Lung Cancer
April 21, 2015
MetaStat CEO Oscar L. Bronsther, M.D. to Participate in Moffitt Cancer Center’s 9th Annual Business of Biotech Conference in Tampa on April 17
April 14, 2015
MetaStat Discussed in Medscape and Other News Outlets
April 9, 2015
MetaStat Appoints Martin J. Driscoll to Board of Directors
April 7, 2015
MetaStat Announces Closing of Series B Private Placement
March 31, 2015
OTC Markets Group Welcomes Newly Verified OTCQB Companies – March 23
March 23, 2015